Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Signal Transduction

Integrin α3β1 Can Function to Promote Spontaneous Metastasis and Lung Colonization of Invasive Breast Carcinoma

Bo Zhou, Katherine N. Gibson-Corley, Mary E. Herndon, Yihan Sun, Elisabeth Gustafson-Wagner, Melissa Teoh-Fitzgerald, Frederick E. Domann, Michael D. Henry and Christopher S. Stipp
Bo Zhou
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine N. Gibson-Corley
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary E. Herndon
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yihan Sun
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Gustafson-Wagner
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Teoh-Fitzgerald
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick E. Domann
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Henry
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher S. Stipp
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
Departments of 1Biology, 2Pathology, 3Molecular Physiology & Biophysics; 4Free Radical and Radiation Biology Program, Department of Radiation Oncology; and 5Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1541-7786.MCR-13-0184 Published January 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Impaired adhesion and spreading of α3 integrin-silenced 4T1 carcinoma cells. A, cell surface biotinylated wild-type (WT), α3si, and α3Rx 4T1 cells were lysed in 1% Triton X-100 detergent and α3β1 integrin was immunoprecipitated using the A3-CYT polyconal antibody (lanes 1–3) or the 9E10 anti-myc epitope antibody (lanes 4–6). The blot was visualized with DyLight 800-Neutravidin. Arrows indicate the α3 and β1 integrin bands. B, quantification of multiple independent blots by LI-COR infrared fluorescent scanner. Data are presented as% wild-type expression ± SEM, n = 6 blots. C, wild-type, α3si, and α3Rx 4T1 cells were plated in wells with different coating concentrations of LM-332. After 25 minutes, nonadherent cells were removed by rinsing, and adherent cells were quantified by crystal violet staining. Compared with wild-type or α3Rx cells, the α3si cells showed significantly reduced adhesion on wells coated 0.5 μg/mL and 1.0 μg/mL LM-332 (*, P < 0.001, ANOVA with Tukey posttest, n = 4 wells/condition). D, wild-type, α3si, and α3Rx 4T1 cells were plated on wells coated with 20 μg/mL collagen I or in BSA-blocked–negative control wells. After 25 minutes, adherent cells were quantified as in (A). E–G, wild-type, α3si, and α3Rx 4T1 cells were plated on glass coverslips coated with 1 μg/mL LM-332 for 30 minutes and then fixed and photographed with differential interference microscopy. H, the spread area of wild-type, α3si, and α3Rx cells was quantified with ImageJ software, as described in Materials and Methods. The spread area of α3si cells was significantly less than wild-type or α3Rx cells (*, P < 0.01, ANOVA with Tukey posttest, n ≥ 98 cells per cell type).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Growth of primary tumors and total tumor burden. On day 0, 5,000 luciferase-expressing 4T1 wild-type, α3si, and α3Rx cells were implanted in the fourth mammary fat pad of female Balb/C mice. A, BLI of the cells on day 10 (when α3si tumor cell burden appeared reduced compared with controls) and day 31 (when α3si tumor cell burden appeared similar to wild-type). B, total apparent tumor burden, measured as log photon flux, for the entire timecourse of the experiment. The α3si tumor cell burden was significantly less than wild-type or α3Rx on days 6 and 10 (*, P < 0.001 vs. wild-type, P < 0.01 vs. α3Rx, ANOVA with Tukey posttest; n = 10 mice per group). The slight reduction in photon flux observed on day 35 was due to the loss of some of the mice with the highest tumor burdens between day 31 and day 35. C, tumor volumes measured by caliper. The mean volume of the α3si tumors was significantly less than the volumes of both the wild-type and α3Rx tumors from day 20 through day 31 (*, P < 0.01 on day 20, and P < 0.05 on days 24–31, ANOVA with Tukey posttest, except for day 27, when α3si was significantly different from α3Rx, but not wild-type).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Spontaneous metastasis is significantly impaired in α3 integrin-silenced 4T1 cells. A, lung colonization as quantified in ex vivo BLI images (see Supplementary Fig. S2B for representative images). The α3si 4T1 cell colonization was significantly reduced compared with wild-type or α3Rx cell colonization (*, P < 0.05 vs. wild-type, P < 0.001 vs. α3Rx, ANOVA with Tukey posttest; n = 10–14 mice per group; bars indicate mean ± SEM). B, wild-type, α3si, and α3Rx 4T1 cells were cell surface biotinylated, and α3β1 integrin was recovered by immunoprecipitation from Triton X-100 lysates, as in Fig. 1. For each set, the lane marked “parental” corresponds to the original cell line implanted into mammary fat pad at the beginning of the assay, and the lanes numbered 1 to 3 correspond to sublines recovered from lung explants at the end of the assay. Quantification of band intensities by LI-COR blot imager is indicated under each lane (in arbitrary intensity units). C, the relationship between primary tumor volume and lung colonization measured by BLI is graphed for each cell type. Values for R2 and P from Pearson correlation tests are shown for each graph. In no case was there a significant correlation between primary tumor volume and lung colonization.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Experimental lung metastasis is significantly impaired in α3 integrin-silenced 4T1 cells. On day 0, 50,000 wild-type, α3si, or α3Rx luciferase-expressing 4T1 cells were injected by tail vein into female Balb/C mice. A, BLI imaging on day 0, immediately after tail vein injection and on day 14, about halfway through the assay. B, total tumor burden (log photon flux) as measured by BLI. Metastatic colonization by the α3si cells was significantly reduced compared with wild-type or α3Rx cells from day 12 onward (*, P < 0.001 vs. wild-type and α3Rx cells, on days 12–20; #, P < 0.05 vs. wild-type and P < 0.001 vs. α3Rx on day 22; and *, P < 0.001 vs. α3Rx on day 26, ANOVA with Tukey posttest, n = 15 mice per group). C, survival to endpoint for mice bearing wild-type, α3si, or α3Rx 4T1 cells. Survival of mice with α3si 4T1 cells was significantly increased compared with mice with wild-type or α3Rx 4T1 cells (P < 0.0001 vs. wild-type and P = 0.0127 vs. α3Rx, Mantel–Cox log-rank test).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Gross and histologic analysis of experimental lung metastasis. A, lungs recovered 18 to 28 days after injection from mice bearing wild-type, α3si, or a3Rx 4T1 cells were paraformaldehyde fixed and photographed using a dissecting microscope before paraffin embedding. Pulmonary metastases appear as pale tan nodules on the surfaces of lungs (arrows point to examples). Fewer nodules were evident on lungs from mice with α3si cells. B, quantification of tumor nodules per 4× field in H&E-stained sections from paraffin-embedded lungs. The α3si 4T1 cells formed fewer nodules than either wild-type or α3Rx 4T1 cells. The wild-type cells formed more nodules than the α3Rx cells, indicating a partial restoration of α3 function for the α3Rx cells in this assay. (*, P < 0.01, ANOVA with Tukey posttest, n = 3 mice per group, 3 slides per mouse, 3 fields per slide, for a total of 27 fields per cell type). Shown at right are representative photomicrographs of lungs from mice injected with (C) wild-type, (D) α3si, or (E) α3Rx 4T1 cells. Asterisks indicate examples of tumor nodules within the pulmonary parenchyma. H&E, bars = 200 μm.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Impaired proliferation of α3si 4T1 cells. Wild-type, α3si, and α3Rx 4T1 cells were plated in 2% FBS in wells coated with 1 μg/mL LM-332, 1 μg/mL LM-511, 10 μg/mL collagen I, or in uncoated wells. One set of wells was assayed by WST-1 on day 0 (the day of plating) to measure cells input, and the remaining wells were assayed on day 2. Bars represent mean ± SEM for 6 wells per cell type per condition, normalized to day 0 values. The growth of the α3si cells was significantly less than that of either the wild-type or α3Rx cells on all substrates tested (*, P < 0.001, ANOVA with Tukey posttest).

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    LAMA5 expression by 4T1 cells. A–C, wild-type, α3si, and α3Rx 4T1 cells were cultured on collagen I-coated coverslips overnight, then fixed and stained with polyclonal anti-LAMA5 antibody. D–F, the merged images show counterstaining for F-actin and nuclei with phalloidin and DAPI. G–I, longer exposure images in cell-free areas highlight LAMA5 deposition on the substrate. J–L, negative control staining with normal rabbit immunoglobulin. M, survival analysis of α3 integrin-overexpressing human breast cancer cases, based on whether or not LAMA5 is also upregulated. LAMA5-overexpressing cases showed reduced survival (P = 0.000403, log-rank test).

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Figure Legends - PDF file, 88K.
    • Supplementary Figures - PDF file, 707K, S1. Comparison of alpha3beta1 and alpha6beta4 integrin expression in 4T1 cell lines. S2. BLI of spontaneous and experimental metastasis (color) S3. Certain large primary mammary fat pad tumors exhibited substantial centralized zones of necrosis. S4. Silencing alpha3 integrin leads to fewer pulmonary metastases following mammary fat pad injection. S5. RNAi-mediated silencing of RhoC has no impact on 4T1 cell metastatic colonization. S6. Cox-2, matrix metalloproteinase, VEGF, and transendothelial migration assays. S7. MDA-MB-231 breast cancer cells do not secrete laminin-332 or laminin-511 or depend on alpha3 integrin in short term proliferation assays.
    • Supplementary Table - PDF file, 38K, Flow cytometry of integrin expression in 4T1 carcinoma cells.
PreviousNext
Back to top
Molecular Cancer Research: 12 (1)
January 2014
Volume 12, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Integrin α3β1 Can Function to Promote Spontaneous Metastasis and Lung Colonization of Invasive Breast Carcinoma
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Integrin α3β1 Can Function to Promote Spontaneous Metastasis and Lung Colonization of Invasive Breast Carcinoma
Bo Zhou, Katherine N. Gibson-Corley, Mary E. Herndon, Yihan Sun, Elisabeth Gustafson-Wagner, Melissa Teoh-Fitzgerald, Frederick E. Domann, Michael D. Henry and Christopher S. Stipp
Mol Cancer Res January 1 2014 (12) (1) 143-154; DOI: 10.1158/1541-7786.MCR-13-0184

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Integrin α3β1 Can Function to Promote Spontaneous Metastasis and Lung Colonization of Invasive Breast Carcinoma
Bo Zhou, Katherine N. Gibson-Corley, Mary E. Herndon, Yihan Sun, Elisabeth Gustafson-Wagner, Melissa Teoh-Fitzgerald, Frederick E. Domann, Michael D. Henry and Christopher S. Stipp
Mol Cancer Res January 1 2014 (12) (1) 143-154; DOI: 10.1158/1541-7786.MCR-13-0184
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Epigenetic Silencing of Thy1 in CD44+/CD24low/CD90+ Myoepithelial Cells
  • ERK Inhibitor Response in KRAS-Mutant Cancer Models
  • Nuclear E-Cadherin Acetylation Enhance β-Catenin Activity
Show more Signal Transduction
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement